• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Outcomes of Concomitant Coronary Artery Bypass Grafting in Patients With Infective Endocarditis: A Systematic Review and Meta-Analysis
It is current practice to perform concomitant coronary artery bypass grafting (CABG) in patients with infective endocarditis who have relevant coronary artery disease. However, CABG may add complexity to the operation. We performed a systematic review and a meta-analysis of studies that presented outcomes from patients who underwent valve surgery because of infective endocarditis with or without concomitant CABG. Three databases were assessed. Perioperative mortality was the primary outcome. Long-term mortality and postoperative stroke were the secondary outcomes.
Source: The American Journal of Cardiology - August 26, 2023 Category: Cardiology Authors: Tulio Caldonazo, Hristo Kirov, Torsten Doenst, Panagiotis Tasoudis, Alexandros Moschovas, Gloria Faerber, Ricardo E. Treml, Michel Pompeu S á, Murat Mukharyamov, Mahmoud Diab Source Type: research

Meta-Analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Narrowing
Randomized controlled trials (RCTs) comparing percutaneous coronary intervention (PCI) with drug-eluting stents and coronary artery bypass grafting (CABG) for patients with left main coronary artery disease (LMCAD) have reported conflicting results. We performed a systematic review up to May 23, 2021, and 1-stage reconstructed individual patient data meta-analysis (IPDMA) to compare outcomes between both groups. The primary outcome was 10-year all-cause mortality. Secondary outcomes included myocardial infarction (MI), stroke, and unplanned revascularization at 5  years.
Source: The American Journal of Cardiology - April 4, 2022 Category: Cardiology Authors: Nicholas W.S. Chew, Chen-Han Ng, Gwyneth Kong, Keng-Siang Lee, Darren J.H. Tan, Oliver Zi-Hern Lim, Yip Han Chin, Bee Choo Tai, Tianyuan Gu, Seung-Jung Park, Duk-Woo Park, Marie-Claude Morice, Theodoros Kofidis, James W.L. Yip, Poay-Huan Loh, Koo-Hui Chan Source Type: research

Outpatient Versus Inpatient Percutaneous Coronary Intervention in Patients with Left Main Disease (From the EXCEL Trial)
Prior studies in patients with non-complex coronary artery disease (CAD) have demonstrated the safety of percutaneous coronary intervention (PCI) in the outpatient setting. We sought to examine the outcomes of outpatient PCI in patients with unprotected left main CAD (LMCAD). In the EXCEL trial, 1905 patients with LMCAD and site-assessed low or intermediate SYNTAX scores were randomized to PCI with everolimus-eluting stents versus coronary artery bypass grafting. The primary endpoint was major adverse cardiovascular events (MACE; the composite of death, stroke, or MI).
Source: The American Journal of Cardiology - December 22, 2020 Category: Cardiology Authors: Prakriti Gaba, Patrick W. Serruys, Dimitri Karmpaliotis, Nicholas J. Lembo, Adrian P. Banning, Zixuan Zhang, Marie-Claude Morice, David E. Kandzari, Anthony H. Gershlick, Ori Ben-Yehuda, Joseph F. Sabik, Arie Pieter Kappetein, Gregg W. Stone Tags: Outpatient Versus Inpatient PCI in EXCEL Source Type: research

Periprocedural Stroke After Coronary Revascularization (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)
There is a scarcity of data on incidence, risk factors, especially clinical severity, and long-term prognostic impact of periprocedural stroke after coronary revascularization in contemporary real-world practice. Among 14867 consecutive patients undergoing first coronary revascularization between January 2011 and December 2013 (percutaneous coronary intervention [PCI]: N=13258, and coronary artery bypass grafting [CABG]: N=1609) in the CREDO-Kyoto PCI/CABG registry Cohort-3, we evaluated the details on periprocedural stroke.
Source: The American Journal of Cardiology - December 3, 2020 Category: Cardiology Authors: Ko Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, Yukiko Matsumura-Nakano, Kenji Nakatsuma, Hiroki Watanabe, Erika Yamamoto, Eri Kato, Masayuki Fuki, Kyohei Yamaji, Ryusuke Nishikawa, Kazuya Nagao, Yasuaki Takeji, Hirotoshi Watanabe, Junich Source Type: research

Outcomes of Transcatheter Aortic Valve Replacement with Percutaneous Coronary Intervention versus Surgical Aortic Valve Replacement with Coronary Artery Bypass Grafting
We aimed to compare the outcomes of combined surgical aortic valve replacement (SAVR) with coronary artery bypass grafting (CABG) to concurrent transcatheter aortic valve replacement (TAVR) with percutaneous coronary intervention (PCI) in a large U.S. population sample. The National Inpatient Sample (NIS) was queried for all patients diagnosed with aortic valve stenosis who underwent SAVR with CABG or TAVR with PCI during the years 2016-2017. Study outcomes included all-cause in-hospital mortality, acute stroke, pacemaker insertion, vascular complications, major bleeding, acute kidney injury, sepsis, non-home discharge, le...
Source: The American Journal of Cardiology - September 25, 2020 Category: Cardiology Authors: Ashraf Abugroun, Mohammed Osman, Saria Awadalla, Lloyd Klein Source Type: research

Drug-eluting Stents Versus Bypass Surgery for Left Main Disease: An updated meta-analysis of randomized controlled trials with long-term follow-up
Debate is ongoing regarding the optimal mode of revascularization for patients with left main coronary artery disease (LMCAD). Longer-term follow-up from randomized trials has recently become available. We recently published a study-level meta-analysis that demonstrated similar mortality after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) when compared with coronary artery bypass grafting (CABG) 1. There were also no differences in cardiac death, stroke or myocardial infarction (MI), although there was a greater risk of unplanned revascularization after PCI.
Source: The American Journal of Cardiology - June 29, 2020 Category: Cardiology Authors: Yousif Ahmad, James P. Howard, Ahran D. Arnold, Ziad A. Ali, Darrel Francis, Jeffrey W. Moses, Martin B. Leon, Ajay J. Kirtane, Dimitri Karmpaliotis, Gregg W. Stone Source Type: research

Meta-analysis Comparing Multiple Arterial Grafts versus Single Arterial Graft for Coronary-Artery Bypass Grafting
Observational studies and randomized controlled trials (RCTs) have shown conflicting outcomes for multiple arterial graft (MAG) coronary artery bypass graft surgery (CABG) compared to single arterial grafts (SAGs). The predominant evidence supporting the use of MAGs is observational. The aim of this meta-analysis of RCTs is to compare outcomes following MAG and SAG. We searched multiple databases for RCTs comparing MAG versus SAG. The clinical outcomes studied were all-cause mortality, cardiac mortality, myocardial infarction (MI), revascularization, stroke, sternal wound complications, and major bleeding.
Source: The American Journal of Cardiology - June 14, 2020 Category: Cardiology Authors: Khalid Changal, Saqib Masroor, Ahmed Elzanaty, Mitra Patel, Tanveer Mir, Shayan Khan, Salik Nazir, Ronak Soni, Carson Oostra, Sadik Khuder, Ehab Eltahawy Source Type: research

Long-term outcomes with drug-eluting stents or coronary artery bypass surgery for unprotected left main coronary disease: A meta-analysis and trial sequential of randomized trials
Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) has emerged as an acceptable revascularization strategy for select patients with unprotected left main coronary disease (LMCA).1 The EXCEL trial showed no difference between DES and coronary artery bypass surgery (CABG) at 5 years for the composite of death, procedure and non-procedure related myocardial infarction (MI), or stroke,2 however; all-cause mortality was higher with DES at 5 years, which was a secondary end-point.
Source: The American Journal of Cardiology - April 13, 2020 Category: Cardiology Authors: Islam Y. Elgendy, Ahmed N. Mahmoud, Mohamed Gad, Akram Y. Elgendy, Deepak L. Bhatt Source Type: research

Characteristics and Outcome of Patients ≥75 Years of Age with Prior Coronary Artery Bypass Grafting Admitted for an Acute Coronary Syndrome
The prognostic role of prior coronary artery bypass (CABG) in elderly patients admitted to hospital for an acute coronary syndrome (ACS) is unclear. Therefore, the aim of this study was to compare the prognosis of patients aged ≥75 years admitted for an ACS with or without prior history of CABG. The primary outcome of the study was a composite of overall mortality, recurrent non-fatal myocardial infarction (MI), non-fatal stroke and re-hospitalization for heart failure at 1-year follow-up. We included 2253 ACS patients, aged 81 (78-85) years enrolled in three multicentre studies (the Italian Elderly ACS study, the LADIES...
Source: The American Journal of Cardiology - April 1, 2020 Category: Cardiology Authors: Nuccia Morici, Roberta De Rosa, Gabriele Crimi, Leonardo De Luca, Luca A. Ferri, Laura Lenatti, Luigi Piatti, Giovanni Tortorella, Daniele Grosseto, Nicoletta Franco, Irene Bossi, Claudio Montalto, Roberto Antonicelli, Gianfranco Alicandro, Giuseppe De Lu Source Type: research

Meta-Analysis comparing Outcomes of Drug Eluting Stents versus Single and Multi-Arterial Coronary Artery Bypass Grafting
Relative benefits of coronary artery bypass (CABG) using single and multiple arterial grafting (SAG, MAG) and drug eluting stent (DES) in multivessel coronary disease remain uncertain. We compared SAG, MAG and DES in a pairwise and network meta-analysis. Randomized trials and adjusted observational studies comparing CABG versus DES were included (primary endpoint: long-term mortality; secondary endpoints: operative mortality, perioperative stroke and follow-up repeated revascularization [RR]). Studies with ≥1.7arterial grafts/patient were classified as MAG.
Source: The American Journal of Cardiology - September 13, 2018 Category: Cardiology Authors: Mario Gaudino, Mohamed Rahouma, Ahmed Abouarab, Derrick Y Tam, Antonino Di Franco, Jeremy Leonard, Umberto Benedetto, Mario Iannaccone, Fabrizio D'Ascenzo, Giuseppe Biondi-Zoccai, Michael Vallely, Leonard N Girardi, Stephen E Fremes, David P Taggart Source Type: research

Meta-Analysis Comparing Outcomes of Drug Eluting Stents Versus Single and Multiarterial Coronary Artery Bypass Grafting
Relative benefits of coronary artery bypass (CABG) using single and multiple arterial grafting (SAG, MAG) and drug eluting stent (DES) in multivessel coronary disease remain uncertain. We compared SAG, MAG, and DES in a pairwise and network meta-analysis. Randomized trials and adjusted observational studies comparing CABG versus DES were included (primary end point: long-term mortality; secondary end points: operative mortality, perioperative stroke, and follow-up repeated revascularization [RR]).
Source: The American Journal of Cardiology - September 13, 2018 Category: Cardiology Authors: Mario Gaudino, Mohamed Rahouma, Ahmed Abouarab, Derrick Y Tam, Antonino Di Franco, Jeremy Leonard, Umberto Benedetto, Mario Iannaccone, Fabrizio D'Ascenzo, Giuseppe Biondi-Zoccai, Michael Vallely, Leonard N Girardi, Stephen E Fremes, David P Taggart Source Type: research

Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents
Patients with unprotected left main coronary artery (ULMCA) disease are increasingly being treated with percutaneous coronary intervention (PCI) using drug-eluting stents (DES), but long-term outcomes comparing PCI with coronary artery bypass grafting (CABG) remain limited. We performed aggregate data meta-analyses of clinical outcomes (all-cause death, nonfatal myocardial infarction, stroke, repeat revascularization, cardiac death, and major adverse cardiac and cerebrovascular events) in studies comparing 5-year outcomes of PCI with DES versus CABG in patients with ULMCA disease.
Source: The American Journal of Cardiology - August 1, 2017 Category: Cardiology Authors: Mahin R. Khan, Waleed T. Kayani, Waqas Ahmad, Ravi S. Hira, Salim S. Virani, Ihab Hamzeh, Hani Jneid, Nasser Lakkis, Mahboob Alam Source Type: research

Meta-Analysis of Comparison of Five-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients with Unprotected Left Main Coronary Artery in the Era of Drug Eluting Stents
Patients with unprotected left main coronary artery (ULMCA) disease are increasingly being treated with percutaneous coronary intervention (PCI) using drug-eluting stents (DES), but long term outcomes comparing PCI with coronary artery bypass grafting (CABG) remain limited. We performed aggregate data meta-analyses of clinical outcomes [all cause death; non-fatal myocardial infarction (MI); stroke; repeat revascularization; cardiac death and major adverse cardiac and cerebrovascular events (MACCE)] in studies comparing 5 year outcomes of PCI with DES vs.
Source: The American Journal of Cardiology - August 1, 2017 Category: Cardiology Authors: Mahin R. Khan, Waleed T. Kayani, Waqas Ahmad, Ravi S. Hira, Salim S. Virani, Ihab Hamzeh, Hani Jneid, Nasser Lakkis, Mahboob Alam Source Type: research

Effect of Preoperative β-Blocker Use on Outcomes Following Cardiac Surgery
Recent studies suggest that the use of preoperative β-blockers in cardiac surgery may not provide improved mortality rates, and may even contribute to negative clinical outcomes. We therefore assessed the role of β-blockers on several outcomes following cardiac surgery (delirium, acute kidney injury (AKI), stroke, atrial fibrillation, mortality, an d hospital length of stay (LOS)) in 4,076 patients who underwent elective coronary artery bypass grafting, coronary artery bypass grafting + valve, or valve cardiac surgery between November 1, 2009 to September 30, 2015 at Vanderbilt Medical Center.
Source: The American Journal of Cardiology - July 24, 2017 Category: Cardiology Authors: Jason B. O'Neal, Frederic T. Billings, Xulei Liu, Matthew S. Shotwell, Yafen Liang, Ashish S. Shah, Jesse M. Ehrenfeld, Jonathan P. Wanderer, Andrew D. Shaw Source Type: research

Effect of Preoperative Beta-Blocker Use on Outcomes Following Cardiac Surgery
Recent studies suggest that the use of preoperative β blockers in cardiac surgery may not provide improved mortality rates and may even contribute to negative clinical outcomes. We therefore assessed the role of β blockers on several outcomes after cardiac surgery (delirium, acute kidney injury [AKI], stroke, atrial fibrillation (AF), mortality, an d hospital length of stay) in 4,076 patients who underwent elective coronary artery bypass grafting, coronary artery bypass grafting + valve, or valve cardiac surgery from November 1, 2009, to September 30, 2015, at Vanderbilt Medical Center.
Source: The American Journal of Cardiology - July 24, 2017 Category: Cardiology Authors: Jason B. O'Neal, Frederic T. Billings, Xulei Liu, Matthew S. Shotwell, Yafen Liang, Ashish S. Shah, Jesse M. Ehrenfeld, Jonathan P. Wanderer, Andrew D. Shaw Source Type: research

Pages: 1  2  3